FDA's decision to regulate all cigars centers around three core arguments:
- FDA believes all cigars pose serious negative health risks
- FDA does not believe that premium cigars sufficiently reduce health risks
- FDA believes premium cigars are used by youth and young adults
FDA suggests that 9,000 lives have been ended early because of cigar smoking. While it does not specify whether or not those are premium cigars, the agency argues it does not have to. Rather, because it does not accept any study on the healthy affects solely premium cigars to be valid—largely due to small sample sizes—it chooses to ague that all cigars are a danger to public health.
FDA's explanation for underage individuals smoking premium cigars is perhaps less grounded. It cites a study that indicates that 3.8 percent of youth aged 12 to 17 indicated they smoked premium cigars, but then discusses in detail, smoking rates for two legal age groups 18 to 25 and 18 to 29. (Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act…, 187-188)
It then states "FDA does not believe it necessary for the definition of premium cigars in this study to match exactly the definitions in the NPRM in order to draw inferences about the use of different types of cigar products... (These data) clearly indicate that youth and young adults are using premium cigars." (Ibid.)
FDA makes it clear that it believes its mandate calls for not only special focus towards underage, illegal tobacco use, but also legal use amongst young adults.
As explained throughout the rest of this guide, all cigars will now be subject to a variety of regulatory measures, including: